
GR Infraprojects shares jump 11% after winning Rs 4,262.78 crore highway project. Discover the details now!
GR Infraprojects shares jump 11% after winning Rs 4,262.78 crore highway project. Discover the details now!
Key levels to watch out for Nifty 50: Market participants expects that the Nifty 50 may breach the 23,000 level…
IRCON shares surge 9% after securing a Rs 1,100 crore contract in Meghalaya. Check out the latest developments!
Markets today at close: Key indices rally with Nifty 50 and BSE Sensex surging over 1.4%; stay tuned for updates.
Small and midcap stocks surge amid positive market sentiment and value buying; explore market dynamics now!
Bajaj Finserv share price today, March 18: Bajaj Group acquires Allianz stakes in joint ventures; Bajaj Finserv share drops amid…
PVR Inox share price today, March 18: Expect 96% upside in PVR Inox as Nuvama points to strong box office…
Blackstone to acquire 66% stake in Kolte Patil; shares surge 4%, then drop. Explore the strategic move in India’s residential…
Nifty surpasses 22,500, buoyed by financial stocks; stay tuned for more updates!
Motilal Oswal recommends buying Kirloskar Oil Engines and Bharti Airtel for future growth potential. Explore investment opportunities now!
Ola Electric shares dive 6% amid legal and financial challenges. Discover the 4 key investor concerns driving this decline.
Wipro share prices plunge amid restructuring and leadership shifts; monitor the company’s next steps in navigating economic challenges.
Monitor the Nifty as it tests critical levels; a breakthrough above 22,500 may spark an uptrend. Track market movements this…
Explore the top 4 metal stocks thriving in 2025 despite global trade uncertainties.
Kotak Institutional Equities issues ‘Sell’ calls on IndusInd Bank, JSW Energy, and NMDC amid market downtrends. Explore their analysis now!
Max Financial named CLSA’s top buy in insurance despite sector slowdown. Explore the reasons behind this strategic choice.
BEL surges 3.2% in Nifty after Rs 2,463 crore radar order from IAF, showing strong growth prospects. Explore opportunities with…
Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!